Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2)

Abstract Introduction Tobacco Heating System (THS) 2.2, a candidate modified-risk tobacco product, aims at offering an alternative to cigarettes for smokers while substantially reducing the exposure to harmful and potentially harmful constituents found in cigarette smoke. Methods One hundred and sixty healthy adult US smokers participated in this randomized, three-arm parallel group, controlled clinical study. Subjects were randomized in a 2:1:1 ratio to menthol Tobacco Heating System 2.2 (mTHS), menthol cigarette, or smoking abstinence for 5 days in confinement and 86 subsequent ambulatory days. Endpoints included biomarkers of exposure to harmful and potentially harmful constituents (reported in our co-publication, Part 1) and biomarkers of potential harm (BOPH). Results Compliance (protocol and allocated product exposure) was 51% and 18% in the mTHS and smoking abstinence arms, respectively, on day 90. Nonetheless, favorable changes in BOPHs of lipid metabolism (total cholesterol and high- and low-density cholesterol), endothelial dysfunction (soluble intercellular adhesion molecule-1), oxidative stress (8-epi-prostaglandin F2α), and cardiovascular risk factors (eg, high-sensitivity C-reactive protein) were observed in the mTHS group. Favorable effects in other BOPHs, including ones related to platelet activation (11-dehydrothromboxane B2) and metabolic syndrome (glucose), were more pronounced in normal weight subjects. Conclusions The results suggest that the reduced exposure demonstrated when switching to mTHS is associated with overall improvements in BOPHs, which are indicative of pathomechanistic pathways underlying the development of smoking-related diseases, with some stronger effects in normal weight subjects. Implications Switching to mTHS was associated with favorable changes for some BOPHs indicative of biological pathway alterations (eg, oxidative stress and endothelial dysfunction). The results suggest that switching to mTHS has the potential to reduce the adverse health effects of smoking and ultimately the risk of smoking-related diseases. Switching to mTHS for 90 days led to reductions in a number of biomarkers of exposure in smokers, relative to those who continued smoking cigarettes, which were close to those observed when stopping smoking (reported in our co-publication, Part 1). Initial findings suggest reduced levels of 8-epi-prostaglandin F2α and intercellular adhesion molecule 1, when switching to mTHS for 90 days. These changes are comparable to what is observed upon smoking cessation. In normal weight subjects, additional favorable changes were seen in 11-dehydrothromboxane B2, fibrinogen, homocysteine, hs-CRP, percentage of predicted forced expiratory volume in 1 second, systolic blood pressure, diastolic blood pressure, glucose, high-density lipoprotein, apolipoprotein A1, and triglycerides. Trial registration NCT01989156.

[1]  P. Wilson,et al.  Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[2]  A. Kondylis,et al.  Comparative assessment of HPHC yields in the Tobacco Heating System THS2.2 and commercial cigarettes , 2017, Regulatory toxicology and pharmacology : RTP.

[3]  D. Postma,et al.  Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers , 2005, European Respiratory Journal.

[4]  R. Weitkunat,et al.  Effects of Switching to the Menthol Tobacco Heating System 2.2, Smoking Abstinence, or Continued Cigarette Smoking on Clinically Relevant Risk Markers: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 2) , 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[5]  M. Peitsch,et al.  Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke. , 2016, Regulatory toxicology and pharmacology : RTP.

[6]  R. Weitkunat,et al.  Reduction in Exposure to Selected Harmful and Potentially Harmful Constituents Approaching Those Observed Upon Smoking Abstinence in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 1) , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[7]  Rémi H. J. Dulize,et al.  In Vitro Systems Toxicology Assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette. , 2016, Chemical research in toxicology.

[8]  G. Assmann,et al.  Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM). , 1999, Atherosclerosis.

[9]  R. Vasan,et al.  Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations , 2006, Circulation.

[10]  Manuel C. Peitsch,et al.  An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe−/− Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  S. Feng,et al.  A 12‐Month, Randomized, Controlled Study to Evaluate Exposure and Cardiovascular Risk Factors in Adult Smokers Switching From Conventional Cigarettes to a Second‐Generation Electrically Heated Cigarette Smoking System , 2008, Journal of clinical pharmacology.

[12]  P. Thirumalaikolundusubramanian,et al.  Lipid and lipoprotein profiles among middle aged male smokers: a study from southern India , 2010, Tobacco induced diseases.

[13]  D. Hatsukami,et al.  The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US , 2009, Tobacco Control.

[14]  P. Lee,et al.  The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes , 2013, Biomarker Research.

[15]  R. Weitkunat,et al.  Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[16]  M. Peitsch,et al.  Aerosol from a candidate modified risk tobacco product has reduced effects on chemotaxis and transendothelial migration compared to combustion of conventional cigarettes. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  Yuh-Min Song,et al.  A short-term smoking cessation may increase the risk of developing metabolic syndrome. , 2015, Diabetes & metabolic syndrome.

[18]  B. Palumbo,et al.  Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). , 2000, Thrombosis research.

[19]  Elena Scotti,et al.  Comparative systems toxicology analysis of cigarette smoke and aerosol from a candidate modified risk tobacco product in organotypic human gingival epithelial cultures: A 3-day repeated exposure study. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  Qi Zhang,et al.  Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. , 1993, Journal of the American College of Cardiology.

[21]  M. Jarvis,et al.  The place for harm reduction and product regulation in UK tobacco control policy. , 2008, Journal of public health.

[22]  Micah L. Berman,et al.  Providing a Science Base for the Evaluation of Tobacco Products. , 2015, Tobacco regulatory science.

[23]  P. Pratte,et al.  Investigation of solid particles in the mainstream aerosol of the Tobacco Heating System THS2.2 and mainstream smoke of a 3R4F reference cigarette , 2017, Human & experimental toxicology.

[24]  Chikako Sakaguchi,et al.  Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting. , 2014, Regulatory toxicology and pharmacology : RTP.

[25]  S. Feng,et al.  Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. , 2008, Regulatory toxicology and pharmacology : RTP.

[26]  J. Magnette,et al.  Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: A one-month, randomized, ambulatory, controlled clinical study in Poland. , 2012, Regulatory toxicology and pharmacology : RTP.

[27]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[28]  R. Wallace,et al.  Clearing the Smoke , 2001 .

[29]  I. Jang,et al.  Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: Eight-day randomized clinical trial in Korea. , 2012, Regulatory toxicology and pharmacology : RTP.

[30]  N. Heidari,et al.  How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in chronic myeloid leukaemia patients? , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[31]  R. Wilson,et al.  Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM‐1, sCD44v5, sCD44v6) , 2002, European journal of clinical investigation.

[32]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[33]  David M. Burns,et al.  The scientific basis of tobacco product regulation. , 2007, World Health Organization technical report series.

[34]  S. Munjal,et al.  Heart Rate Variability Increases With Reductions in Cigarette Smoke Exposure After 3 Days , 2009, Journal of cardiovascular pharmacology and therapeutics.

[35]  A. Tricker,et al.  Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-Day randomized clinical trial of a menthol cigarette in Japan. , 2012, Regulatory toxicology and pharmacology : RTP.

[36]  M. Peitsch,et al.  Aerosol from Tobacco Heating System 2.2 has reduced impact on mouse heart gene expression compared with cigarette smoke. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[37]  Ashraf Elamin,et al.  A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[38]  D. Lúdvíksdóttir,et al.  Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation , 1999, Journal of internal medicine.

[39]  H. Rodríguez-Hernández,et al.  Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation , 2013, International journal of endocrinology.

[40]  B. Palumbo,et al.  Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults. , 2000, VASA. Zeitschrift fur Gefasskrankheiten.

[41]  M. Unverdorben,et al.  Short term effects of reduced exposure to cigarette smoke on white blood cells, platelets and red blood cells in adult cigarette smokers. , 2010, Regulatory toxicology and pharmacology : RTP.

[42]  S. Feng,et al.  Short‐Term Clinical Exposure Evaluation of a Second‐Generation Electrically Heated Cigarette Smoking System , 2007, Journal of clinical pharmacology.

[43]  S. Munjal,et al.  Effects of Different Levels of Cigarette Smoke Exposure on Prognostic Heart Rate and Rate—Pressure-Product Parameters , 2008, Journal of cardiovascular pharmacology and therapeutics.

[44]  Ashraf Elamin,et al.  A systems toxicology approach for comparative assessment: Biological impact of an aerosol from a candidate modified-risk tobacco product and cigarette smoke on human organotypic bronchial epithelial cultures. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.

[45]  C. Leroy,et al.  Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-Day randomized clinical trial in Japan. , 2012, Regulatory toxicology and pharmacology : RTP.

[46]  J. Morrow,et al.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.

[47]  Megan E. Piper,et al.  Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. , 2011, American heart journal.

[48]  P. Vanscheeuwijck,et al.  Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. , 2016, Regulatory toxicology and pharmacology : RTP.

[49]  A. Luch,et al.  Levels of selected analytes in the emissions of “heat not burn” tobacco products that are relevant to assess human health risks , 2018, Archives of Toxicology.

[50]  S. Tonstad,et al.  C-reactive protein as a predictor of disease in smokers and former smokers: a review , 2009, International journal of clinical practice.

[51]  K. Farsalinos,et al.  Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e‐cigarette and a tobacco cigarette , 2018, Addiction.

[52]  Acute effects of cigarette smoking on pulmonary function. , 2010, Regulatory toxicology and pharmacology : RTP.

[53]  H. Sinzinger,et al.  Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia. , 1999, Wiener klinische Wochenschrift.

[54]  Manuel C. Peitsch,et al.  Comprehensive systems biology analysis of a 7-month cigarette smoke inhalation study in C57BL/6 mice , 2016, Scientific Data.

[55]  S. Feng,et al.  Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[56]  R. Weitkunat,et al.  Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 1) , 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[57]  M C Peitsch,et al.  Systems toxicology meta-analysis of in vitro assessment studies: biological impact of a candidate modified-risk tobacco product aerosol compared with cigarette smoke on human organotypic cultures of the aerodigestive tract† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7tx , 2017, Toxicology research.

[58]  S. Feng,et al.  12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. , 2008, Regulatory toxicology and pharmacology : RTP.

[59]  Q. Liang,et al.  Effects of levels of cigarette smoke exposure on symptom-limited spiroergometry. , 2007, Preventive cardiology.

[60]  M Feinleib,et al.  Obesity and lipoprotein cholesterol in the Framingham offspring study. , 1980, Metabolism: clinical and experimental.

[61]  Å. Westin,et al.  Effect of smoking reduction and cessation on cardiovascular risk factors. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[62]  R. Kinser,et al.  Short‐Term Exposure Evaluation of Adult Smokers Switching From Conventional to First‐Generation Electrically Heated Cigarettes During Controlled Smoking , 2005, Journal of clinical pharmacology.

[63]  G. Scherer.  Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review. , 2018, Regulatory toxicology and pharmacology : RTP.

[64]  Megan E. Piper,et al.  Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk , 2017, Arteriosclerosis, thrombosis, and vascular biology.